PCN58 A Comprehensive Cost-Effectiveness Analysis of Lenalidomide for Multiple Myeloma Patients who Have Received at Least One Prior Therapy
Jun 1, 2012, 00:00 AM
10.1016/j.jval.2012.03.1175
https://www.valueinhealthjournal.com/article/S1098-3015(12)01240-5/fulltext
Section Title :
Cancer
Section Order :
695
First Page :
A218
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01240-5&doi=10.1016/j.jval.2012.03.1175